Loading data for FTH — first visit, this takes a few seconds.
Faeth Therapeutics Inc. (FTH)
NasdaqCM: FTH
· 실시간 가격 · USD
33.00
+0.23 (0.70%)
종가 기준: Aug 18, 2026, 8:00 PM
34.00
+3.03%
프리마켓: 7:52 AM
Faeth Therapeutics Inc. (FTH) Stock Price, Analysis & Data
0.70% (1D)
데이터 없음
FTH 소개
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The...
전체 기업 정보재무 실적
2025년 Faeth Therapeutics의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -21.09M로, -30.08% 감소했습니다.
재무제표어닝 서프라이즈
Faeth Therapeutics가 Aug 4, 2026에 분기 실적을 발표했습니다:
